Keyphrases
Body Clearance
7%
CaSi
7%
Continuous Intravenous Infusion
7%
Cytotoxicity
7%
Data Evaluation
7%
Diarrhea
7%
Dose-independent
7%
Elimination Half-life
7%
Escalating Dose
7%
Fluorouracil
100%
Inter-patient
7%
Intra-patient
7%
Maximum Tolerated Dose
7%
Optimal Dose
7%
Optimal Schedule
7%
Patients with Advanced Cancer
100%
Pharmacokinetic Study
100%
Pharmacokinetics
7%
Phase I Study
7%
Phase II Study
7%
Plasma Pharmacokinetics
100%
Portents
7%
Recombinant Interferon alpha-2b
100%
Steady-state Plasma Concentration
7%
Stomatitis
7%
Total-body
7%
Ultra-high Performance Liquid Chromatography (UHPLC)
7%
Volume of Distribution
7%
Pharmacology, Toxicology and Pharmaceutical Science
Advanced Cancer
100%
Cytotoxicity
7%
Diarrhea
7%
Elimination
7%
Fluorouracil
100%
Hyperbarism
7%
Maximum Tolerated Dose
7%
Noma
7%
Pharmacokinetics
100%
Recombinant Alpha2b Interferon
100%
Volume of Distribution
7%
Agricultural and Biological Sciences
Blood Level
7%
Blood Plasma
100%
Cytotoxicity
7%
High-Performance Liquid Chromatography
7%
Interferon Alfa 2b
100%
Malignant Neoplasm
100%
Pharmacokinetics
100%
Plasma Concentration
7%
Immunology and Microbiology
Blood Level
7%
Blood Plasma
100%
Cytotoxicity
7%
Elimination Half-Life
7%
Liquid Chromatography
7%
Maximum Tolerated Dose
7%
Noma
7%
Optimal Drug Dose
7%
Pharmacokinetics
100%
Recombinant Alpha2b Interferon
100%
Steady State
7%